Skip to content
Discover the best deals, discounts, and offers in the Nethe…

Zimbabwe Turns Down ‘Unbalanced’ American Healthcare Assistance Deal Over Data Fears

Medical aid image
The proposed American financial assistance would have supported initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years because of Washington's insistence on confidential information.

The decision became public after a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa believed the deal was "lopsided".

A government spokesperson has since clarified that the US was seeking health data for research and profit but was unwilling to guarantee the resulting advantages from future medical innovations.

"We are forced to start the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has urged more talks to reach a agreement acceptable to both sides so the nation's critical HIV treatment initiative can proceed.

Wider Background

This development comes after a comparable case in Kenya, where a court blocked a similar deal with the US following concerns were raised about the security of citizens' health data.

After resuming office recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.

The agency had managed assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to enhance transparency and accountability.

Based on statements, 16 African countries have so far agreed to similar agreements, representing more than $18.3bn of fresh investment.

Details of the Rejected Deal

The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this partnership would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment via US-supported programmes," Tremont said.

However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".

"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.

"In essence, our country would provide the raw materials for medical research without any assurance that the end products would be available to our population should a future pandemic arise."

Sovereignty and International Frameworks

He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending systems previously established via the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage future global health emergencies.

"This system is intended to guarantee that when a country provides its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.

"We welcome continued dialogue with our US partners on how subsequent co-operation could be designed in a manner that respects the sovereignty and interests of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that talks need to persist considering much of the country's Aids initiatives relied on foreign aid.

"If technical issues arise, such as those involving data governance or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," it said.

The situation highlights the continuing tensions between receiving crucial international aid and protecting national sovereignty in an ever more interconnected world.

About the author

Patricia Church

Erik is a Dutch deal-hunter and writer who loves exploring local markets and sharing money-saving tips with readers.

Harbor Deals Guide

Type to search articles.